BeOne Medicines (BEIGF) Net Cash Flow Growth (3y) (2018 - 2026)
BeOne Medicines (BEIGF) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
- |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-13.44% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
38.47% |
| Date | Value |
|---|
| Mar 31, 2026 |
38.47% |
| Dec 31, 2025 |
47.67% |
| Sep 30, 2025 |
89.73% |
| Jun 30, 2025 |
-3.87% |
| Mar 31, 2025 |
-43.94% |
| Dec 31, 2024 |
-26.13% |
| Sep 30, 2024 |
29.44% |
| Jun 30, 2024 |
-11.34% |
| Mar 31, 2024 |
-38.89% |
| Dec 31, 2023 |
38.75% |
| Sep 30, 2023 |
-71.78% |
| Jun 30, 2023 |
53.88% |
| Mar 31, 2023 |
-31.13% |
| Dec 31, 2022 |
-10.52% |
| Sep 30, 2022 |
-118.07% |
| Jun 30, 2022 |
17.43% |
| Mar 31, 2022 |
-41.99% |
| Dec 31, 2021 |
393.81% |
| Sep 30, 2021 |
-53.32% |
| Jun 30, 2021 |
-54.01% |
